eli lilly oral tirzepatide weight loss drug data released Eli Lilly says next-gen obesity
Description
Are there any dietary considerations when taking GLP-1 medications
A new commentary published in Diabetes, Obesity and Metabolism shares practical recommendations for gathering real world evidence on the use of GLP-1 medications in people with Prader-Willi syndrome
Among the unreported adverse events potentially linked to Ozempic are two deaths and one case of completed suicide, according to an FDA inspection report.
We found that liraglutide dosed animals showed no significant differences in disease progression when compared to vehicle dosed animals in either the SOD1G93A or TDP-43Q331K mouse models of ALS
The FDA urges healthcare professionals to stop administering the products, and patients should stop using them.
